Cargando…
Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway
BACKGROUND: Reverse cholesterol transport (RCT) is an important cardioprotective mechanism and the decrease in cholesterol efflux can result in the dyslipidemia. Although liraglutide, a glucagon like peptide-1 analogue, has mainly impacted blood glucose, recent data has also suggested a beneficial e...
Autores principales: | Wu, Ya-Ru, Shi, Xiao-Yun, Ma, Chun-Yan, Zhang, Yue, Xu, Rui-Xia, Li, Jian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842145/ https://www.ncbi.nlm.nih.gov/pubmed/31706303 http://dx.doi.org/10.1186/s12933-019-0954-6 |
Ejemplares similares
-
In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012) -
Rosmarinic Acid Increases Macrophage Cholesterol Efflux through Regulation of ABCA1 and ABCG1 in Different Mechanisms
por: Nyandwi, Jean-Baptiste, et al.
Publicado: (2021) -
Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP‐1‐derived macrophages
por: Wang, Limei, et al.
Publicado: (2016) -
Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1
por: Ren, Kun, et al.
Publicado: (2019) -
Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs
por: He, Yi, et al.
Publicado: (2023)